Key clinical point: The adoption of techniques for post-ERCP pancreatitis (PEP) prophylaxis in clinical practice appears to deviate from the evidence.
Major finding: About 40% of endoscopists use rectal NSAIDs for patients at average risk of PEP.
Study details: A survey of 233 advanced endoscopists involved in fellowship training programs.
Disclosures: The authors did not report any study funding or disclosures.
Avila P et al. Gastrointest Endosc. 2019 Nov 16. doi: 10.1016/j.gie.2019.11.013.